Literature DB >> 14501190

Evolution of surface and nonstructural-1 genes of influenza B viruses isolated in the Province of Québec, Canada, during the 1998-2001 period.

Yacine Abed1, Michael B Coulthart, Yan Li, Guy Boivin.   

Abstract

After 2 minor winter seasons, influenza B viruses were predominantly isolated in the Province of Quebec, Canada, during the 2000-2001 season representing 74% of laboratory-confirmed influenza viruses. We performed an antigenic study of the hemagglutinin (HA) protein and a molecular characterization of the HA1 region, nonstructural-1 (NS1) and neuraminidase (NA)/NB genes of 20 influenza B strains isolated in the Province of Quebec during the 1998-2001 period. Our isolates were compared to recent vaccine strains (B/Harbin/7/94 in 1998-1999, B/Yamanashi/166/98 in 1999-2000 and 2000-2001, and B/Sichuan/379/99 in 2001-2002). The hemagglutination inhibition (HI) test revealed that all isolates were different from B/Harbin/7/94 and were more related to the 2 other vaccine strains although precise identification was often impossible. Molecular analysis of the HA1 gene revealed that both B/Yamanashi/166/98-like and B/Sichuan/379/99-like isolates co-circulated during the 1998-1999 season whereas isolates from the 2 subsequent years were more related to B/Sichuan/379/99. Most isolates (8/9) of the 2000-2001 season contained a N126D substitution recently associated with altered antigenicity in recent influenza B/Yamagata/16/88-related viruses. Although the HA1 and NS1 protein sequences of viruses isolated during the 1998-1999 season were clearly different from those of the respective vaccine strain (B/Harbin/7/94), the NA protein sequence of those isolates was slightly more related to B/Harbin/7/94 than B/Yamanashi/166/98 suggesting distinct patterns of evolution for these genes. This study confirms the importance of a detailed molecular analysis for understanding the evolution of influenza B viruses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14501190     DOI: 10.1023/a:1025768308631

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  29 in total

1.  Reassortment and insertion-deletion are strategies for the evolution of influenza B viruses in nature.

Authors:  J A McCullers; G C Wang; S He; R G Webster
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Evolutionary changes in influenza B are not primarily governed by antibody selection.

Authors:  G M Air; A J Gibbs; W G Laver; R G Webster
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

3.  Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983.

Authors:  P A Rota; T R Wallis; M W Harmon; J S Rota; A P Kendal; K Nerome
Journal:  Virology       Date:  1990-03       Impact factor: 3.616

4.  Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation.

Authors:  D C Wiley; I A Wilson; J J Skehel
Journal:  Nature       Date:  1981-01-29       Impact factor: 49.962

5.  Antigenic and genetic analyses of influenza type B viruses isolated in Russia, 1987-91.

Authors:  M L Hemphill; P A Rota; V T Ivanova; A N Slepushkin; A P Kendal
Journal:  Epidemiol Infect       Date:  1993-12       Impact factor: 2.451

6.  Evolutionary characteristics of influenza B virus since its first isolation in 1940: dynamic circulation of deletion and insertion mechanism.

Authors:  R Nerome; Y Hiromoto; S Sugita; N Tanabe; M Ishida; M Matsumoto; S E Lindstrom; T Takahashi; K Nerome
Journal:  Arch Virol       Date:  1998       Impact factor: 2.574

7.  Recent influenza B viruses in Europe: a phylogenetic analysis.

Authors:  N Ikonen; L Kinnunen; T Forsten; R Pyhälä
Journal:  Clin Diagn Virol       Date:  1996-06

8.  Complete nucleotide sequence of the neuraminidase gene of influenza B virus.

Authors:  M W Shaw; R A Lamb; B W Erickson; D J Briedis; P W Choppin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

9.  Emergence of an influenza B virus with antigenic change.

Authors:  Naoko Nakagawa; Souichi Nukuzuma; Shigekazu Haratome; Shosan Go; Toshimasa Nakagawa; Kozaburo Hayashi
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

10.  The antigenic structure of the influenza B virus hemagglutinin: operational and topological mapping with monoclonal antibodies.

Authors:  M T Berton; R G Webster
Journal:  Virology       Date:  1985-06       Impact factor: 3.616

View more
  6 in total

1.  Structural basis for the divergent evolution of influenza B virus hemagglutinin.

Authors:  Fengyun Ni; Elena Kondrashkina; Qinghua Wang
Journal:  Virology       Date:  2013-08-27       Impact factor: 3.616

2.  Diversifying selective pressure on influenza B virus hemagglutinin.

Authors:  Jun Shen; Brian D Kirk; Jianpeng Ma; Qinghua Wang
Journal:  J Med Virol       Date:  2009-01       Impact factor: 2.327

3.  Crystal structure of unliganded influenza B virus hemagglutinin.

Authors:  Qinghua Wang; Feng Cheng; Mingyang Lu; Xia Tian; Jianpeng Ma
Journal:  J Virol       Date:  2008-01-09       Impact factor: 5.103

4.  Genetic characterisation of influenza B viruses detected in Singapore, 2004 to 2009.

Authors:  Muhammad Raihan Jumat; Richard J Sugrue; Boon-Huan Tan
Journal:  BMC Res Notes       Date:  2014-12-01

5.  Genetic analysis of influenza B viruses isolated in Uganda during the 2009-2010 seasons.

Authors:  Denis K Byarugaba; Bernard Erima; Monica Millard; Hannah Kibuuka; Lukwago L; Josephine Bwogi; Derrick Mimbe; Edison A Mworozi; Bridget Sharp; Scott Krauss; Richard J Webby; Robert G Webster; Samuel K Martin; Fred Wabwire-Mangen; Mariette F Ducatez
Journal:  Virol J       Date:  2013-01-05       Impact factor: 4.099

6.  Integrating influenza antigenic dynamics with molecular evolution.

Authors:  Trevor Bedford; Marc A Suchard; Philippe Lemey; Gytis Dudas; Victoria Gregory; Alan J Hay; John W McCauley; Colin A Russell; Derek J Smith; Andrew Rambaut
Journal:  Elife       Date:  2014-02-04       Impact factor: 8.140

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.